These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IL-12 and IL-23: master regulators of innate and adaptive immunity. Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388 [TBL] [Abstract][Full Text] [Related]
3. The novel interleukin-1 cytokine family members in inflammatory diseases. Hahn M; Frey S; Hueber AJ Curr Opin Rheumatol; 2017 Mar; 29(2):208-213. PubMed ID: 27926540 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases. Egwuagu CE; Yu CR; Sun L; Wang R Cytokine Growth Factor Rev; 2015 Oct; 26(5):587-93. PubMed ID: 26279360 [TBL] [Abstract][Full Text] [Related]
8. The biological paths of IL-1 family members IL-18 and IL-33. Smith DE J Leukoc Biol; 2011 Mar; 89(3):383-92. PubMed ID: 20952658 [TBL] [Abstract][Full Text] [Related]
9. [Recent progress in the pathophysiological role of interleukin-19]. Fujimoto Y; Azuma YT Nihon Yakurigaku Zasshi; 2019; 154(2):66-71. PubMed ID: 31406045 [TBL] [Abstract][Full Text] [Related]
10. The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases. Palomo J; Dietrich D; Martin P; Palmer G; Gabay C Cytokine; 2015 Nov; 76(1):25-37. PubMed ID: 26185894 [TBL] [Abstract][Full Text] [Related]
11. Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Conti P; Youinou P; Theoharides TC Autoimmun Rev; 2007 Jan; 6(3):131-7. PubMed ID: 17289547 [TBL] [Abstract][Full Text] [Related]
12. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases. Leng RX; Pan HF; Tao JH; Ye DQ Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280 [TBL] [Abstract][Full Text] [Related]
13. Advances in IL-21 biology - enhancing our understanding of human disease. Tangye SG Curr Opin Immunol; 2015 Jun; 34():107-15. PubMed ID: 25801685 [TBL] [Abstract][Full Text] [Related]
14. The interleukins of fish. Secombes CJ; Wang T; Bird S Dev Comp Immunol; 2011 Dec; 35(12):1336-45. PubMed ID: 21605591 [TBL] [Abstract][Full Text] [Related]
15. IL-21 enhances SOCS gene expression and inhibits LPS-induced cytokine production in human monocyte-derived dendritic cells. Strengell M; Lehtonen A; Matikainen S; Julkunen I J Leukoc Biol; 2006 Jun; 79(6):1279-85. PubMed ID: 16551679 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-35: the future of hyperimmune-related diseases? Ye S; Wu J; Zhou L; Lv Z; Xie H; Zheng S J Interferon Cytokine Res; 2013 Jun; 33(6):285-91. PubMed ID: 23472662 [TBL] [Abstract][Full Text] [Related]
17. Emerging role of interleukin-33 in autoimmune diseases. Pei C; Barbour M; Fairlie-Clarke KJ; Allan D; Mu R; Jiang HR Immunology; 2014 Jan; 141(1):9-17. PubMed ID: 24116703 [TBL] [Abstract][Full Text] [Related]
18. The role of interleukins and their inhibitors in the development of autoimmune uveitis. Kuryltsiv NB; Halei KM Wiad Lek; 2019; 72(4):716-722. PubMed ID: 31055563 [TBL] [Abstract][Full Text] [Related]
19. IL-21: roles in immunopathology and cancer therapy. Søndergaard H; Skak K Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910 [TBL] [Abstract][Full Text] [Related]